Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Dusa Pharmaceuticals Inc (DUSA) since 2010 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Dusa Pharmaceuticals Inc. Table 2 shows the detailed insider transactions. This company's CIK number is 879993.
Total stock buying since 2010: $37,039.
Total stock sales since 2010: $6,017,575.
Total stock option exercises since 2010: $560,571.
▪ Statistics of price movements of DUSA
▪ Recent SEC 13D filings for all companies
▪ Recent portfolio reports of all companies
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2012 | 0 | $0 | 36,875 | $214,296 | 89,375 | $219,590 |
| 2011 | 5,000 | $20,269 | 1,256,690 | $5,803,279 | 145,725 | $324,481 |
| 2010 | 7,000 | $16,770 | 0 | $0 | 15,000 | $16,500 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2012-11 | 0 | $0 | 0 | $0 | 7,500 | $12,000 |
| 2012-03 | 0 | $0 | 36,875 | $214,296 | 81,875 | $207,590 |
| 2011-08 | 5,000 | $20,269 | 0 | $0 | 0 | $0 |
| 2011-05 | 0 | $0 | 125,725 | $745,056 | 125,725 | $293,381 |
| 2011-03 | 0 | $0 | 1,130,965 | $5,058,223 | 20,000 | $31,100 |
| 2010-08 | 7,000 | $16,770 | 0 | $0 | 0 | $0 |
| 2010-06 | 0 | $0 | 0 | $0 | 15,000 | $16,500 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2012-11-13 | Christopher Richard (VP Finance & CFO) | Option Ex | 7,500 | 1.60 | 12,000 |
| 2012-03-16 | Lundahl Scott L (VP, Regulatory Affairs & IP) | Sale | 17,500 | 5.79 | 101,360 |
| 2012-03-16 | Lundahl Scott L (VP, Regulatory Affairs & IP) | Option Ex | 17,500 | 1.60 | 28,000 |
| 2012-03-13 | Haft Jay M (Director) | Option Ex | 20,000 | 2.71 | 54,100 |
| 2012-03-12 | Marcus Stuart L (VP, Sc. Aff & CMO) | Sale | 19,375 | 5.83 | 112,936 |
| 2012-03-12 | Marcus Stuart L (VP, Sc. Aff & CMO) | Option Ex | 19,375 | 2.73 | 52,990 |
| 2012-03-08 | Bartash David M (Director) | Option Ex | 25,000 | 2.90 | 72,500 |
| 2011-08-11 | Altomari Alfred (Director) | Buy | 2,000 | 4.06 | 8,119 |
| 2011-08-09 | Haft Jay M (Director) | Buy | 3,000 | 4.05 | 12,150 |
| 2011-05-16 | Lundahl Scott L (VP, Regulatory Affairs & IP) | Sale | 1,000 | 5.96 | 5,960 |
| 2011-05-16 | Lundahl Scott L (VP, Regulatory Affairs & IP) | Option Ex | 1,000 | 1.22 | 1,220 |
| 2011-05-13 | Carota Mark (Vice President, Operations) | Sale | 36,875 | 5.89 | 217,378 |
| 2011-05-13 | Carota Mark (Vice President, Operations) | Option Ex | 36,875 | 2.23 | 82,231 |
| 2011-05-13 | Lundahl Scott L (VP, Regulatory Affairs & IP) | Sale | 17,500 | 5.95 | 104,125 |
| 2011-05-13 | Lundahl Scott L (VP, Regulatory Affairs & IP) | Option Ex | 17,500 | 3.87 | 67,725 |
| 2011-05-12 | Todisco Michael (Vice President, Controller) | Sale | 27,800 | 5.92 | 164,464 |
| 2011-05-12 | Todisco Michael (Vice President, Controller) | Option Ex | 27,800 | 1.22 | 33,916 |
| 2011-05-12 | Christopher Richard (VP Finance & CFO) | Sale | 42,550 | 5.95 | 253,129 |
| 2011-05-12 | Christopher Richard (VP Finance & CFO) | Option Ex | 42,550 | 2.54 | 108,289 |
| 2011-03-22 | Deerfield Special Situations Fund International Ltd | Sale | 94,000 | 4.34 | 408,242 |
| 2011-03-21 | Deerfield Special Situations Fund International Ltd | Sale | 93,224 | 4.57 | 425,567 |
| 2011-03-18 | Deerfield Special Situations Fund International Ltd | Sale | 3,200 | 4.61 | 14,752 |
| 2011-03-17 | Deerfield Special Situations Fund International Ltd | Sale | 447,111 | 4.59 | 2,052,686 |
| 2011-03-16 | Deerfield Special Situations Fund International Ltd | Sale | 68,430 | 4.58 | 313,751 |
| 2011-03-15 | Deerfield Special Situations Fund International Ltd | Sale | 425,000 | 4.34 | 1,843,225 |
| 2011-03-08 | Moliteus Magnus (Director) | Option Ex | 20,000 | 1.55 | 31,100 |
| 2010-08-30 | Wurzer David M (Director) | Buy | 5,000 | 2.35 | 11,730 |
| 2010-08-05 | Altomari Alfred (Director) | Buy | 2,000 | 2.52 | 5,040 |
| 2010-06-08 | Lesser Marvin E (Director) | Option Ex | 15,000 | 1.10 | 16,500 |
Insider trading activities including stock purchases, stock sales, and option exercises of DUSA listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Dusa Pharmaceuticals Inc (symbol DUSA, CIK number 879993) see the Securities and Exchange Commission (SEC) website.